Keeping a home clean requires more than just basic sweeping and dusting. Modern households face daily challenges such as pet hair, food crumbs, dust buildup, muddy footprints, and stubborn floor stains. In 2026, vacuum cleaners have become smarter and more efficient, helping homeowners save time while maintaining cleaner and healthier living spaces. Advanced cleaning technology [...]
Lucid Diagnostics (NASDAQ:LUCD) reported first-quarter 2026 EsoGuard test volume above its pre-Medicare target range, while management said it continues to await a Medicare local coverage determination and is expanding efforts with the Department of Veterans Affairs, commercial payers and health sys
Kyivstar Group (NASDAQ:KYIV) reported double-digit first-quarter growth and raised its full-year 2026 outlook, citing resilient telecom demand, expanding digital platforms and continued cash generation despite operating in Ukraine during wartime.
Chief Executive Officer Oleksandr Komarov said Kyivs
Legence LGN (NASDAQ:LGN) reported sharply higher first-quarter 2026 revenue and adjusted EBITDA, driven by strong demand for mission-critical building systems, growth in data center and technology projects, and the contribution from its Bowers Group acquisition.
Chief Executive Officer Jeff Sprau s
Chicago Atlantic BDC (NASDAQ:LIEN) reported record first-quarter 2026 net investment income as management pointed to strong loan deployments, a senior secured portfolio and limited exposure to interest-rate declines as key drivers of performance.
Chief Executive Officer Peter Sack said the company’
Karooooo (NASDAQ:KARO) reported accelerated subscription revenue growth and sharply higher adjusted free cash flow for fiscal 2026, while management said it expects further growth in fiscal 2027 despite near-term pressure on gross margins from foreign exchange and higher device-related costs.
Durin
Kolibri Global Energy (NASDAQ:KGEI) reported what management described as the strongest quarter in the company’s history for several operating and financial metrics, with President and CEO Wolf E. Regener saying first-quarter 2026 results included record quarterly production, net revenue and adjuste
Karyopharm Therapeutics (NASDAQ:KPTI) said it entered 2026 with several near-term clinical and regulatory catalysts, led by new Phase 3 data in myelofibrosis and an expected midyear readout in endometrial cancer, while reporting higher first-quarter revenue and reaffirming full-year guidance.
On th
Crescent Capital BDC (NASDAQ:CCAP) reported a more difficult first quarter as higher non-accruals, lower base rates and broader credit-market volatility weighed on earnings and net asset value, prompting management to lower fees and reset the company’s base dividend.
Chief Executive Officer Jason B
